IDIA
IDORSIA N
Stock SIX Swiss Exchange – Stock Market Prices, News & Analysis
Idorsia is a Swiss biopharmaceutical company specializing in the research and development of innovative new drugs.
IDORSIA N
IDIA
Idorsia is a Swiss biopharmaceutical company specializing in the research and development of innovative new drugs.
Price history of IDORSIA N
Price history of IDORSIA N
Performance & Momentum
Strategic Analysis
IDORSIA N • 2026
Idorsia is a Swiss biopharmaceutical company focused on the discovery and development of innovative treatments, with the typical profile of a research-driven company with strong scientific intensity. Its appeal rests mainly on its ability to turn a pipeline of projects into commercial assets, in a niche where value is created through clinical innovation and intellectual property.
- Clear positioning in pharmaceutical innovation and breakthrough biotechnology
- Significant valuation potential if the clinical pipeline and future launches deliver on their promise
- Exposure to a long-term sector driven by demand for new treatments
- High-risk profile linked to dependence on the success of clinical trials and regulatory approvals
- Very poor long-term share price history, reflecting substantial operational fragility and still-limited market confidence
Current momentum is clearly more favorable than the long-term track record, with a trend that has recently turned constructive after a prolonged period of underperformance. This suggests a renewed speculative interest or an improvement in market perception of the story, but volatility remains high and the stock is still primarily a bet on clinical and commercial execution.
Similar stocks to IDORSIA N
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
